Cargando…

Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication

Syndecan-1, a cell surface heparan sulfate proteoglycan, is critically involved in the differentiation and prognosis of various tumors. In this review, we highlight the synthesis, cellular interactions, and the signalling pathways regulated by syndecan-1. The basal syndecan-1 level is also crucial f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szatmári, Tünde, Ötvös, Rita, Hjerpe, Anders, Dobra, Katalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569789/ https://www.ncbi.nlm.nih.gov/pubmed/26420915 http://dx.doi.org/10.1155/2015/796052

Ejemplares similares

Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1
por: Szatmári, Tünde, et al.
Publicado: (2017)

Novel Genes and Pathways Modulated by Syndecan-1: Implications for the Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells
por: Szatmári, Tünde, et al.
Publicado: (2012)

The Role of Syndecan-1 in Cellular Signaling and its Effects on Heparan Sulfate Biosynthesis in Mesenchymal Tumors
por: Szatmári, Tünde, et al.
Publicado: (2013)

Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells
por: Javadi, Joman, et al.
Publicado: (2021)

Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells
por: Kumar-Singh, Ashish, et al.
Publicado: (2021)

Specific Syndecan-1 Domains Regulate Mesenchymal Tumor Cell Adhesion, Motility and Migration
por: Zong, Fang, et al.
Publicado: (2011)

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies
por: Mundt, Filip, et al.
Publicado: (2014)

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions
por: Hillerdal, Carl-Olof, et al.
Publicado: (2017)

Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells
por: Kumar-Singh, Ashish, et al.
Publicado: (2020)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
por: Szulkin, Adam, et al.
Publicado: (2014)

Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma
por: Ötvös, Rita, et al.
Publicado: (2015)

Multiplex Soluble Biomarker Analysis from Pleural Effusion
por: Javadi, Joman, et al.
Publicado: (2020)

Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
por: Hjerpe, Anders, et al.
Publicado: (2020)

Cytoskeletal Organization Correlates to Motility and Invasiveness of Malignant Mesothelioma Cells
por: Keller, Maureen, et al.
Publicado: (2021)

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology
por: Hjerpe, Anders, et al.
Publicado: (2022)

Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma
por: Mundt, Filip, et al.
Publicado: (2014)

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
por: Javadi, Joman, et al.
Publicado: (2021)

Inhibitors of cytoskeletal dynamics in malignant mesothelioma
por: Reis, Katarina, et al.
Publicado: (2020)

Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma
por: Darai-Ramqvist, Eva, et al.
Publicado: (2013)

Variation in Drug Sensitivity of Malignant Mesothelioma Cell Lines with Substantial Effects of Selenite and Bortezomib, Highlights Need for Individualized Therapy
por: Szulkin, Adam, et al.
Publicado: (2013)

Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1
por: Hollósi, Péter, et al.
Publicado: (2020)

Prognostic significance of syndecan-1 expression in cervical cancers
por: Kim, Yu Im, et al.
Publicado: (2011)

Syndecan-1 in Liver Diseases
por: Regős, Eszter, et al.
Publicado: (2019)

Aberrant Expression of Syndecan-1 in Cervical Cancers
por: Karászi, Katalin, et al.
Publicado: (2020)

Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-Localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells
por: Zong, Fang, et al.
Publicado: (2009)

Syndecans in tumor cell adhesion and signaling
por: Beauvais, DeannaLee M, et al.
Publicado: (2004)

Syndecan-Regulated Receptor Signaling
por: Rapraeger, Alan C.
Publicado: (2000)

Extracellular Vesicles in Modifying the Effects of Ionizing Radiation
por: Szatmári, Tünde, et al.
Publicado: (2019)

Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma
por: Mundt, Filip, et al.
Publicado: (2013)

Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis
por: Wei, Hao-tang, et al.
Publicado: (2015)

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer
por: Santos, Nilton José, et al.
Publicado: (2021)

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
por: Loussouarn, D, et al.
Publicado: (2008)

Syndecan-1 expression has prognostic significance in head and neck carcinoma
por: Anttonen, A, et al.
Publicado: (1999)

Evaluation of the Diagnostic and Prognostic Value of Syndecan-1 in Acute Leukemia Patients
por: Alghandour, Reham, et al.
Publicado: (2020)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

In Vivo Irradiation of Mice Induces Activation of Dendritic Cells
por: Persa, Eszter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ue8ogoav1rhkeci5hjtft9d45u